Quantum Genesis AI (QGAI) Stock Overview

A biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. More details

QGAI fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has less than 1 year of cash runway

Negative shareholders equity

Makes less than USD$1m in revenue ($0)

Does not have a meaningful market cap ($7M)

+ 1 more risk

QGAI Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

UNCYFeatured

Looking to be second time lucky with a game-changing new product

Key Takeaways Unicycive has successfully completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC has been designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability over alternative treatments for hyperphosphatemia chronic kidney disease patients on dialysis.

View narrative

stuart_roberts

Community Contributor

US$21.53FV • 67.8% undervalued

5419.8%Revenue growth p.a.

5.4k

110

2mo ago

Quantum Genesis AI Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Quantum Genesis AI
Historical stock prices
Current Share Price	US$0.16
52 Week High	US$5.04
52 Week Low	US$0.0025
Beta	31.7
1 Month Change	-60.00%
3 Month Change	-94.97%
1 Year Change	-87.79%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-84.00%

Recent updates

Shareholder Returns

	QGAI	US Biotechs	US Market
7D	0%	5.0%	3.5%
1Y	-87.8%	40.4%	31.0%

Return vs Industry: QGAI underperformed the US Biotechs industry which returned 33.3% over the past year.

Return vs Market: QGAI underperformed the US Market which returned 23.7% over the past year.

Price Volatility

Is QGAI's price volatile compared to industry and market?
QGAI volatility
QGAI Average Weekly Movement	108.0%
Biotechs Industry Average Movement	11.2%
Market Average Movement	7.1%
10% most volatile stocks in US Market	16.4%
10% least volatile stocks in US Market	3.3%

Stable Share Price: QGAI's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: QGAI's weekly volatility has decreased from 939% to 108% over the past year, but is still higher than 75% of US stocks.

About the Company

Founded	Employees	CEO	Website
2015	n/a	Naveen Kulkarni	qgaicorp.com

Quantum Genesis AI Corp., a biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer centric research to enhance enzyme activity, by applying quantum mechanics, molecular modelling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support production. The company was formerly known as Quantumzyme Corp. and changed its name to Quantum Genesis AI Corp. in February 2026.

Quantum Genesis AI Corp. Fundamentals Summary

How do Quantum Genesis AI's earnings and revenue compare to its market cap?
QGAI fundamental statistics
Market cap	US$6.56m
Earnings (TTM)	-US$4.49m
Revenue (TTM)	n/a

0.0x

P/S Ratio

-1.5x

P/E Ratio

Is QGAI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
QGAI income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$4.49m
Earnings	-US$4.49m

Last Reported Earnings

Jan 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)	-0.11
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	-55.5%

How did QGAI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/04/04 18:12
End of Day Share Price	2026/04/02 00:00
Earnings	2026/01/31
Annual Earnings	2025/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Quantum Genesis AI Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Quantum Genesis AI Corp.OTCPK:QGAI Stock Report